QSP Modeling Shows Pathological Synergism Between Insulin Resistance and Amyloid‐Beta Exposure in Upregulating VCAM1 Expression at the BBB Endothelium
Zengtao Wang(University of Minnesota), Karunya K. Kandimalla(University of Minnesota)
Cited by 3
Related Papers
Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis
|Journal of Pharmacology and Experimental Therapeutics|2019|61
Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood–Brain Barrier Endothelium
|Molecular Pharmacology|2023|11
Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood–Brain Barrier
|Molecular Pharmaceutics|2024|10
Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease
|Journal of Pharmacology and Experimental Therapeutics|2024|8